Familial hyperthyroidism due to mutations in TSH receptor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:424OMIM:609152E05.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial hyperthyroidism due to mutations in the TSH receptor (also known as familial non-autoimmune autosomal dominant hyperthyroidism, or hereditary toxic thyroid hyperplasia) is a rare genetic disorder caused by gain-of-function mutations in the TSHR gene, which encodes the thyroid-stimulating hormone (TSH) receptor. These mutations lead to constitutive activation of the TSH receptor, meaning the receptor is permanently switched on even without TSH stimulation. This results in unregulated overproduction of thyroid hormones by the thyroid gland, causing hyperthyroidism that is not mediated by autoimmune mechanisms — distinguishing it from Graves' disease. The condition primarily affects the endocrine system, specifically the thyroid gland, and can present with symptoms typical of hyperthyroidism including tachycardia (rapid heart rate), weight loss, heat intolerance, tremor, irritability, anxiety, diarrhea, and diffuse goiter (enlarged thyroid). In some families, the condition manifests in infancy or childhood, while in others it may not become clinically apparent until adulthood. Affected individuals characteristically have suppressed TSH levels with elevated free T3 and free T4, and importantly, thyroid autoantibodies (such as TSH receptor antibodies) are absent. Treatment can be challenging because the hyperthyroidism tends to relapse after discontinuation of antithyroid drugs (such as methimazole or propylthiouracil), since the underlying cause is a permanently activated receptor rather than an autoimmune process. Definitive treatment typically requires thyroid ablation, either through total thyroidectomy (surgical removal of the thyroid) or radioiodine therapy, followed by lifelong thyroid hormone replacement. Early recognition and genetic testing are important for distinguishing this condition from autoimmune hyperthyroidism and for screening at-risk family members.

Also known as:

Clinical phenotype terms— hover any for plain English:

Activating thyroid-stimulating hormone receptor defectHP:0011790Thyroid hyperplasiaHP:0008249Thyrotoxicosis with diffuse goiterHP:0011784Abnormal eye morphologyHP:0012372
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Jan 2023Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects

Istituto Auxologico Italiano

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Familial hyperthyroidism due to mutations in TSH receptor.

View clinical trials →

No actively recruiting trials found for Familial hyperthyroidism due to mutations in TSH receptor at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Familial hyperthyroidism due to mutations in TSH receptor community →

No specialists are currently listed for Familial hyperthyroidism due to mutations in TSH receptor.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial hyperthyroidism due to mutations in TSH receptor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial hyperthyroidism due to mutations in TSH receptorForum →

No community posts yet. Be the first to share your experience with Familial hyperthyroidism due to mutations in TSH receptor.

Start the conversation →

Latest news about Familial hyperthyroidism due to mutations in TSH receptor

Disease timeline:

New recruiting trial: Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects

A new clinical trial is recruiting patients for Familial hyperthyroidism due to mutations in TSH receptor

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Familial hyperthyroidism due to mutations in TSH receptor

What is Familial hyperthyroidism due to mutations in TSH receptor?

Familial hyperthyroidism due to mutations in the TSH receptor (also known as familial non-autoimmune autosomal dominant hyperthyroidism, or hereditary toxic thyroid hyperplasia) is a rare genetic disorder caused by gain-of-function mutations in the TSHR gene, which encodes the thyroid-stimulating hormone (TSH) receptor. These mutations lead to constitutive activation of the TSH receptor, meaning the receptor is permanently switched on even without TSH stimulation. This results in unregulated overproduction of thyroid hormones by the thyroid gland, causing hyperthyroidism that is not mediated b

How is Familial hyperthyroidism due to mutations in TSH receptor inherited?

Familial hyperthyroidism due to mutations in TSH receptor follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.